However, more studies are needed to assess how the positioning of inflamed vessels within the tumor parenchyma models their immunomodulatory phenotypes (tolerogenic versus immunostimulatory) and whether the IFN‐EC subtype in responders is accrued at the tumor‐stroma interface to facilitate the infiltration of CD8+ T‐cells. The gene discussed is CD8A; the disease is neoplasm.